News | February 07, 2026
Novo Nordisk threatens legal action over Hims & Hers ‘knockoff’ semaglutide pill
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
As CRISPR and prime editing applications advance, researchers increasingly rely on longer guide RNAs to boost editing efficiency and reduce off-target effects
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The pioneering monoclonal antibody is for Essential Thrombocythemia (ET) and Polycythemia Vera (PV), rare chronic blood cancers with limited treatment options
The newly certified kits are designed for early detection and large-scale screening programs
In the SHORE phase 3 study, amlitelimab, used in combination with topical therapies, met all primary and key secondary endpoints at Week 24
The collaboration will center on expanding access to Eastman’s Esmeri technology
EMA recommended 30 veterinary medicines for marketing authorisation in 2025
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
GlideTech materials are available in several standard base resins and offer customization options for specific applications
Subscribe To Our Newsletter & Stay Updated
